579 related articles for article (PubMed ID: 33065440)
1. Design, synthesis of novel 4,5-dihydroisoxazole-containing benzamide derivatives as highly potent FtsZ inhibitors capable of killing a variety of MDR Staphylococcus aureus.
Song D; Bi F; Zhang N; Qin Y; Liu X; Teng Y; Ma S
Bioorg Med Chem; 2020 Nov; 28(21):115729. PubMed ID: 33065440
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators.
Bi F; Song D; Zhang N; Liu Z; Gu X; Hu C; Cai X; Venter H; Ma S
Eur J Med Chem; 2018 Nov; 159():90-103. PubMed ID: 30268826
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 1,3,4-oxadiazol-2-one-containing benzamide derivatives targeting FtsZ as highly potent agents of killing a variety of MDR bacteria strains.
Bi F; Song D; Qin Y; Liu X; Teng Y; Zhang N; Zhang P; Zhang N; Ma S
Bioorg Med Chem; 2019 Jul; 27(14):3179-3193. PubMed ID: 31200986
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents.
Song D; Zhang N; Zhang P; Zhang N; Chen W; Zhang L; Guo T; Gu X; Ma S
Eur J Med Chem; 2021 Oct; 221():113480. PubMed ID: 33964649
[TBL] [Abstract][Full Text] [Related]
5. 2,6-Difluorobenzamide Inhibitors of Bacterial Cell Division Protein FtsZ: Design, Synthesis, and Structure-Activity Relationships.
Straniero V; Zanotto C; Straniero L; Casiraghi A; Duga S; Radaelli A; De Giuli Morghen C; Valoti E
ChemMedChem; 2017 Aug; 12(16):1303-1318. PubMed ID: 28586174
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and on-target antibacterial activity of novel 3-elongated arylalkoxybenzamide derivatives as inhibitors of the bacterial cell division protein FtsZ.
Ma S; Cong C; Meng X; Cao S; Yang H; Guo Y; Lu X; Ma S
Bioorg Med Chem Lett; 2013 Jul; 23(14):4076-9. PubMed ID: 23770057
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological activity evaluation of novel 2,6-difluorobenzamide derivatives through FtsZ inhibition.
Bi F; Guo L; Wang Y; Venter H; Semple SJ; Liu F; Ma S
Bioorg Med Chem Lett; 2017 Feb; 27(4):958-962. PubMed ID: 28082038
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and structure-activity relationships of substituted oxazole-benzamide antibacterial inhibitors of FtsZ.
Stokes NR; Baker N; Bennett JM; Chauhan PK; Collins I; Davies DT; Gavade M; Kumar D; Lancett P; Macdonald R; Macleod L; Mahajan A; Mitchell JP; Nayal N; Nayal YN; Pitt GR; Singh M; Yadav A; Srivastava A; Czaplewski LG; Haydon DJ
Bioorg Med Chem Lett; 2014 Jan; 24(1):353-9. PubMed ID: 24287381
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of novel 4-bromo-1H-indazole derivatives as FtsZ inhibitors.
Wang Y; Yan M; Ma R; Ma S
Arch Pharm (Weinheim); 2015 Apr; 348(4):266-74. PubMed ID: 25773717
[TBL] [Abstract][Full Text] [Related]
10. Structural and Antibacterial Characterization of a New Benzamide FtsZ Inhibitor with Superior Bactericidal Activity and In Vivo Efficacy Against Multidrug-Resistant
Bryan E; Ferrer-González E; Sagong HY; Fujita J; Mark L; Kaul M; LaVoie EJ; Matsumura H; Pilch DS
ACS Chem Biol; 2023 Mar; 18(3):629-642. PubMed ID: 36854145
[TBL] [Abstract][Full Text] [Related]
11. TXA709, an FtsZ-Targeting Benzamide Prodrug with Improved Pharmacokinetics and Enhanced In Vivo Efficacy against Methicillin-Resistant Staphylococcus aureus.
Antimicrob Agents Chemother; ; . PubMed ID: 26033735
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
